MarginsXMarginsX
Home › Markets › Health Care › ANIK

Anika Therapeutics Inc. (ANIK)

ANIK trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$12.92
-3.58% on the day
Market cap
$173.1M
Micro cap
Revenue · 2025
$112.8M
-5.9% on 2024
Net income · 2025
-$10.9M
-9.6% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/898437/000117184326001275/0001171843-26-001275-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerANIK on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000898437
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$112.8M
Net income-$10.9M
Operating income-$11.1M
Net margin-9.6%
Operating margin-9.8%
Revenue growth-5.9%
Cash$57.5M
Total assets$190.3M
P/E (computed)Net income was not positive
P/S (computed)1.5×

Warning signs

Cash runway
Cash-flow positive
$45.0M cash at September 30, 2026
Share count, 1 year
-7.1%
2025-10-29 to 2026-10-30 · -8.5% over 3 years
Going-concern doubt
No
10-Q filed November 6, 2026
Insider net buying, 12 months
$264K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-06
Cash and burn$45.0M cash; operating cash flow $1.9M a quarter.Report 2026-09-30
Shares outstanding13,395,313 (2026-10-30); 14,421,219 a year earlier; 14,640,886 three years earlier.Cover page 2026-10-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorDeloitte & Touche LLP, Boston, Massachusetts, United StatesPCAOB Form AP 2026-03-06
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $264K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$30.6M-$311K$8.4M$45.0MNo debt tags$123.4M10-Q 2026-11-06
Q2 2026
2026-06-30
$32.6M$3.3M-$684K$38.4MNo debt tags$120.7M10-Q 2026-07-29
Q1 2026
2026-03-31
$29.6M-$5.1M-$4.8M$41.0MNo debt tags$116.3M10-Q 2026-04-30
Q4 2025
2025-12-31
$30.6M$292K$4.6M$57.5MNo debt tags$112.8M10-K 2026-03-03
Q3 2025
2025-09-30
$27.8M-$2.3M$6.9M$58.0MNo debt tags$112.8M10-Q 2026-11-06
Q2 2025
2025-06-30
$28.2M-$4.0M-$189K$53.2MNo debt tags$114.5M10-Q 2026-07-29
Q1 2025
2025-03-31
$26.2M-$4.9M-$130K$53.4MNo debt tags$117.1M10-Q 2026-04-30
Q4 2024
2024-12-31
$30.6M-$21.9M$1.6M$55.6MNo debt tags$119.9M10-K 2026-03-03

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest annual report
FORM 10-K
10-K2026-03-03
Latest quarterly / interim
FORM 10-Q
10-Q2026-11-06
Latest current report
FORM 8-K
8-K2026-11-06
Latest proxyDEFA14A2026-06-08

Source: SEC EDGAR submissions feed, 1,006 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-7.9%
1 month-34.7%
3 months-36.7%
Year to date+39.4%
1 year+32.7%
From 52-week high-39.2%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
KRMDKORU Medical Systems Inc. Common Stock (DE)$3.69-0.27%$160.1M
KTWOK2 Capital Acquisition Corporation Class A Ordinary Share$10.13+0.05%$203.0M
UTMDUtah Medical Products Inc.$72.36+0.54%$206.2M
PDEXPro-Dex Inc.$64.48-1.80%$206.3M
PYPDPolyPid Ltd.$6.15-1.76%$124.9M
LUNGPulmonx Corporation$2.80-2.10%$121.9M
STIMNeuronetics Inc.$1.25-10.07%$120.6M
OSUROraSure Technologies Inc.$3.60-0.55%$248.6M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier